Hereditary hemorrhagic telangiectasia
MONDO:0019180A disorder of angiogenesis leading to arteriovenous dilatations: cutaneo-mucosal hemorrhagic telangiectasias and visceral shunting.
Also known as: HHT, Osler-Weber-Rendu disease, Rendu-Osler disease, Rendu-Osler-Weber disease, hereditary hemorrhagic telangiectasia, telangiectasia, hereditary Hemorrahagic, of Rendu, Osler, telangiectasia, hereditary hemorrhagic
39 clinical trials for this condition and its sub-types, 34 tagged with Hereditary hemorrhagic telangiectasia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Hereditary hemorrhagic telangiectasia
-
New ointment could tame HHT nosebleeds
Symptom relief Not yet recruitingThis early-phase trial tests a new nasal ointment called TOR-582, which contains sirolimus, in 27 adults with hereditary hemorrhagic telangiectasia (HHT) who have frequent nosebleeds. Participants apply the ointment inside their nostrils twice daily for 12 weeks, with different s…
Phase 1 • Sponsor: Columbia University • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
New study to measure daily life impact of rare bleeding disorder in youth
Knowledge-focused Not yet recruitingThis study looks at how hereditary hemorrhagic telangiectasia (HHT) affects the quality of life of children and young adults aged 2 to 25. Participants will fill out questionnaires about their physical, emotional, and social well-being. Researchers will also review medical record…
Sponsor: Ashley Nelson • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC